# Grace Therapeutics, Inc.: Form 8-K, filed Jul 5, 2023

- Company: [Grace Therapeutics, Inc.](/companies/grce.md) (CIK 1444192)
- Form: 8-K
- Filed: 2023-07-05
- Accepted by EDGAR: Jul 5, 2023, 16:00 ET
- Period: 2023-07-05
- Accession: 0000950170-23-031612
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1444192/000095017023031612/acst-20230705.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1444192/000095017023031612/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1444192/000095017023031612/acst-20230705.htm

Filed Jul 5, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-031612. Last ingested by Listed: Nov 12, 2026, 18:09 ET. No prices; not investment advice.